trending Market Intelligence /marketintelligence/en/news-insights/trending/tCMI_hvGGudrIceIPCxOjw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Biocept to undertake $2.2M private placement

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Biocept to undertake $2.2M private placement

Ally Bridge LB Healthcare Master Fund Ltd. is investing some $2.2 million in Biocept Inc. by acquiring 1,466,667 shares of the company at $1.50 apiece.

The shares come bundled with five-year warrants to buy up to an additional 1,434,639 stocks, also at $1.50 apiece.

The offering is expected to close Aug. 10.

Biocept and Ally Bridge's Chinese affiliate are also in discussions to evaluate potential strategic opportunities to leverage the company's liquid biopsy platform in China.

The company was granted patents covering its proprietary technology in China.